Phase III Randomized Study of Poloxamer 188 for Vaso-Occlusive Crisis of Sickle Cell Disease

Trial Profile

Phase III Randomized Study of Poloxamer 188 for Vaso-Occlusive Crisis of Sickle Cell Disease

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Jun 2014

At a glance

  • Drugs Poloxamer 188 (Primary)
  • Indications Sickle cell anaemia
  • Focus Registrational; Therapeutic Use
  • Sponsors Mast Therapeutics
  • Most Recent Events

    • 17 Jun 2014 New trial record
    • 05 Mar 2012
    • 08 Feb 2012
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top